Dr. Cagri Savran
Founder & CSO

Dr. Cagri Savran, Founder & CSO

Cagri is the inventor of the underlying technology. His R&D experience of over 20 years across multiple disciplines has generated 30 patents and patent applications on devices including optical biosensors, biological micro-manipulators and high throughput microfluidic systems. Dr. Savran holds a BS in Mechanical Engineering from Purdue University, and an MS and a PhD in Mechanical Engineering from MIT. He is currently a Professor of Mechanical Engineering and Biomedical Engineering at Purdue University.

Simon Turner

Simon Turner is a highly experienced international finance and operations executive. Simon uses strategic thinking and a highly detailed, data driven approach to focus commercial activities and to effectively align internal functions behind them. Simon has successfully managed sales, marketing, finance, accounting, IT, HR and administration functions, lately at Oxford Immunotec Global, Abcodia and CR Worldwide.
At Oxford Immunotec Global, a UK based global diagnostic company, Simon joined as employee number 7 and during his 10-year period as head of finance, the company grew to $50 million in revenues with operations in the UK, US and Japan. He successfully managed consistent growth rates of 60-70% pa over that period and executed on four rounds of VC funding raising over $70 million. Oxford successfully exited through a $250 million IPO on NASDAQ and key to that successful exit was a project led by Simon that doubled US gross margins over a 9-month period. At Abcodia, Simon led a cross functional team that delivered a CLIA certified laboratory from scratch in 120 days.
Simon has a Master’s degree in chemical engineering from Imperial College, London, a Masters in Finance from London Business School and is a qualified chartered accountant (UK). In addition, Simon is treasurer for IERG, an international networking organization and President of the London Business School alumni club of New England.

Dr. Chun-Li Chang
Director of R&D

Dr. Chun Li Chang
Chun-Li is a Research Professor at Purdue University and the co-inventor of Savran Tech’s primary technology. He has 13 years of hands on experience in bioinstrumentation, chemical conjugation, bodily fluid handling, cell culturing, device design and microfabrication as well as technical personnel management. Dr. Chang holds a BS in Electrical Engineering from National Chiao Tung University in Taiwan, and a PhD in Electrical Engineering from Purdue University.

Jeff Behrens
Member of the Board of Directors

Jeff Behrens is founder and CEO of LabShares Newton, a biotech incubator for biotech startups run by biotech entrepreneurs. Formerly, Jeff was President and CEO of Siamab Therapeutics, a biotech company focused on developing antibodies targeting glycan targets in cancer that exited in 2018. Previously, Jeff served as Senior Director, Business Development and Operations at Edimer Pharmaceuticals (funded by Third Rock Ventures) and also worked at Alnylam and Biogen Idec, where co-founded Biogen’s Innovation Incubator. In 2003 Jeff sold his healthcare IT company, The Telluride Group, to mindSHIFT Technologies, a Fidelity-funded rollup. Jeff has an MS from the Harvard/MIT Division of Health Sciences and Technology (HST), an MBA from MIT Sloan, and graduated from Harvard College. He teaches HST590, a PhD level course at MIT and lives in Newton, MA.

Nadia Altomare
Member of the Board of Directors

Nadia Altomare is the Chief Commercial Officer of Sera Prognostics Inc., a global leader in high-value women’s health diagnostics. She is focused on its breakthrough diagnostics product where she is leading the commercial business strategy and implementing the building blocks for widespread payer coverage. Previously, as President and then CEO at Abcodia Ltd, a clinical-stage company engaged in using human serum-based biomarkers to develop validated tests for the early detection of cancer, Nadia set up the U.S. subsidiary and oversaw the subsequent launch of global commercial operations. Prior to Abcodia, Nadia was Vice President & General Manager at ThermoFisher Scientific, a multinational biotechnology product development company. Her early career was spent through a series mergers and acquisitions and an IPO, resulting in a company ultimately acquired by PerkinElmer. Among her accomplishments was the startup, build and scale of the ViaCord division. Nadia received an MBA from Northeastern University and a BS in Business Administration from SUNY Stony Brook.